EQL — EQL Pharma AB | ScreenerHero

EQLEQL Pharma AB

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic

26.00SEKMkt Cap: 767.77M SEKP/E: 61.90Last update: 2026-05-21

Industry Peers

Drug Manufacturers - Specialty & Generic

Swedish Orphan Biovitrum AB (publ)

153.14BSEKP/E 168.3

54.96BEURP/E 21.7

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

52.53BTRYP/E 25.1

33.63BPLNP/E 21.9

BioGaia AB (publ)

13.36BSEKP/E 40.3

13.24BEURP/E 30.2

Deva Holding A.S.

Siegfried Holding AG

3.54BCHFP/E 21.0

loading…

Indicators:|

Key Statistics

Company

Market Cap767.77M SEK

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)—

Revenue/Share—

Last Price26.00 SEK

Fiscal Year End—

MR Quarter—

Employees—

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINSE0005497732

Valuation

P/E (Trailing)61.90

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B—

EPS (TTM)—

EPS (Forward)—

52W Range

24.55100% of range26.00

52W High26.00 SEK

52W Low24.55 SEK

Profitability

Gross Margin—

Oper. Margin—

EBITDA Margin—

Profit Margin—

ROE—

ROA—

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF—

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio—

Quick Ratio—

Book Value/Sh—

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate—

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float—

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta—

S&P 52W Chg—

Avg Vol (30d)153.71K

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—